Emmanuel Kiyonga, a 28-year-old Ugandan pharmacist, has poured his heart into a discovery that could change lives. His new drug, Raloxifene Hydrochloride Solvate-Hydrate, aims to improve breast cancer treatment for postmenopausal women, and it’s already making waves. Driven by a deep desire to save lives, Kiyonga’s work earned him R100,000, approximately $5,225, and the title … Continue reading Uganda’s Emmanuel Kiyonga develops postmenopausal breast cancer drug